Clinical Applications of a Non-ablative Fractional Dual Laser (1550/1927 nm)
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The non-ablative fractional dual laser is equipped with two types of lasers, 1550 nm and 1927 nm in one device, and was approved by the United States Food and Drug Administration in 2013. The advantages of the non-ablative fractional laser (NAFL) include fewer side effects such as erythema, edema, post-laser pigmentation, and scab formation. Thus, the NAFL is preferred by both practitioners and consumers because it is convenient and safe for use. The 1550 nm erbium glass and 1927 nm thulium lasers are representative NAFLs that have been developed separately and are often used as a single-wavelength laser with proven clinical efficacy in various indications. The 1550 nm wavelength laser penetrates the dermis layer and the 1927 nm wavelength laser is effective for epidermal lesions. Therefore, targeting the skin layer can be easily achieved with both the 1550 and 1927 nm lasers, respectively, or in combination. Clinically, the 1550 nm laser is effective in the treatment of mild to moderate sagging and wrinkles, scars, and resurfacing. The 1927 nm laser improves skin texture and treats skin pigmentation and wounds. It can also be used for drug delivery. The selection and utilization rate of NAFL has been increasing in recent times, due to changes in lifestyle patterns and the need for beauty treatments with fewer side effects and short downtime. In this study, we present a plan for safe and effective laser therapy through a review of literature. Clinical applications of the multifunctional NAFL are also described.
Abstract
The non-ablative fractional dual laser is equipped with two types of lasers, 1550 nm and 1927 nm in one device, and was approved by the United States Food and Drug Administration in 2013. The advantages of the non-ablative fractional laser (NAFL) include fewer side effects such as erythema, edema, post-laser pigmentation, and scab formation. Thus, the NAFL is preferred by both practitioners and consumers because it is convenient and safe for use. The 1550 nm erbium glass and 1927 nm thulium lasers are representative NAFLs that have been developed separately and are often used as a single-wavelength laser with proven clinical efficacy in various indications. The 1550 nm wavelength laser penetrates the dermis layer and the 1927 nm wavelength laser is effective for epidermal lesions. Therefore, targeting the skin layer can be easily achieved with both the 1550 and 1927 nm lasers, respectively, or in combination. Clinically, the 1550 nm laser is effective in the treatment of mild to moderate sagging and wrinkles, scars, and resurfacing. The 1927 nm laser improves skin texture and treats skin pigmentation and wounds. It can also be used for drug delivery. The selection and utilization rate of NAFL has been increasing in recent times, due to changes in lifestyle patterns and the need for beauty treatments with fewer side effects and short downtime. In this study, we present a plan for safe and effective laser therapy through a review of literature. Clinical applications of the multifunctional NAFL are also described.
참고문헌 (39)
- Ong MW, "Fractional laser resurfacing for acne scars : a review", Br J Dermatol, 166, pp.1160~1169 (2012)
- Finney R, "Non-ablative fractional resurfacing in the treatment of scar contracture", Lasers Surg Med, 48, pp.170~173 (2016)
- Wat H, "Fractional resurfacing in the Asian patient : current state of the art", Lasers Surg Med, 49, pp.45~59 (2017)
- Taudorf EH, "Non-ablative fractional laser provides long-term improvement of mature burn scars--a randomized controlled trial with histological assessment", Lasers Surg Med, 47, pp.141~147 (2015)
- Park KY, "Comparison of fractional, nonablative, 1550-nm laser and 595-nm pulsed dye laser for the treatment of facial erythema resulting from acne : a splitface, evaluator-blinded, randomized pilot study", J Cosmet Laser Ther, 16, pp.120~123 (2014)
- Lipozenčić J, "Will nonablative rejuvenation replace ablative lasers? Facts and controversies", Clin Dermatol, 31, pp.718~724 (2013)
- Monstrey S, "Updated scar management practical guidelines : non-invasive and invasive measures", J Plast Reconstr Aesthet Surg, 67, pp.1017~1025 (2014)
- Carniol PJ, "Current status of fractional laser resurfacing", JAMA Facial Plast Surg, 17, pp.360~366 (2015)
- Kim DW, "Outcomes of ablative fractional laser scar treatment", J Plast Surg Hand Surg, 49, pp.88~94 (2015)
- Rinnerthaler M, "Oxidative stress in aging human skin", Biomolecules, 5, pp.545~589 (2015)
- Lephart ED, "Skin aging and oxidative stress : equol's anti-aging effects via biochemical and molecular mechanisms", Ageing Res Rev, 31, pp.36~54 (2016)
- Farage MA, "Intrinsic and extrinsic factors in skin ageing : a review", Int J Cosmet Sci, 30, pp.87~95 (2008)
- Alexiades-Armenakas MR, "The spectrum of laser skin resurfacing : nonablative, fractional, and ablative laser resurfacing", J Am Acad Dermatol, 58, pp.719~737 (2008)
- Sachdeva S, "Nonablative fractional laser resurfacing in Asian skin--a review", J Cosmet Dermatol, 9, pp.307~312 (2010)
- Alajlan AM, "Acne scars in ethnic skin treated with both non-ablative fractional 1, 550 nm and ablative fractional CO2 lasers : comparative retrospective analysis with recommended guidelines", Lasers Surg Med, 43, pp.787~791 (2011)
- Chua SH, "Nonablative infrared skin tightening in Type IV to V Asian skin : a prospective clinical study", Dermatol Surg, 33, pp.146~151 (2007)
- Clark CM, "A retrospective chart review to assess the safety of nonablative fractional laser resurfacing in Fitzpatrick skin types IV to VI", J Drugs Dermatol, 12, pp.428~431 (2013)
- Brauer JA, "Nonablative 1927 nm fractional resurfacing for the treatment of facial photopigmentation", J Drugs Dermatol, 13, pp.1317~1322 (2014)
- Cohen BE, "Acne scarring : a review of available therapeutic lasers", Lasers Surg Med, 48, pp.95~115 (2016)
- Rivera AE, "Acne scarring : a review and current treatment modalities", J Am Acad Dermatol, 59, pp.659~676 (2008)
- Liu Y, "The long-term effect of 1550 nm erbium : glass fractional laser in acne vulgaris", Lasers Med Sci, 31, pp.453~457 (2016)
- Bogle MA, "Evaluation of the 1, 540-nm erbium : glass laser in the treatment of inflammatory facial acne", Dermatol Surg, 33, pp.810~817 (2007)
- Moneib H, "Randomized split-face controlled study to evaluate 1550-nm fractionated erbium glass laser for treatment of acne vulgaris--an image analysis evaluation", Dermatol Surg, 40, pp.1191~1200 (2014)
- Angel S, "Treatment of active acne with an er : glass(1. 54 microm)laser : a 2-year follow-up study", J Cosmet Laser Ther, 8, pp.171~176 (2006)
- Lim HK, "Nonablative fractional laser as a tool to facilitate skin penetration of 5-aminolaevulinic acid with minimal skin disruption : a preliminary study", Br J Dermatol, 170, pp.1336~1340 (2014)
- Park KY, "Appropriate timing for thyroidectomy scar treatment using a 1, 550-nm fractional erbium-glass laser", Dermatol Surg, 39, pp.1827~1834 (2013)
- Lee HS, "Treatment of melasma in Asian skin using a fractional 1, 550-nm laser : an open clinical study", Dermatol Surg, 35, pp.1499~1504 (2009)
- Kwon SH, "Melasma : updates and perspectives", Exp Dermatol, 28, pp.704~708 (2019)
- Rongsaard N, "Comparison of a fractional bipolar radiofrequency device and a fractional erbium-doped glass 1, 550-nm device for the treatment of atrophic acne scars : a randomized split-face clinical study", Dermatol Surg, 40, pp.14~21 (2014)
- Hasegawa J, "Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin", Pigment Cell Melanoma Res, 21, pp.687~699 (2008)
- Kim JY, "Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma", J Invest Dermatol, 133, pp.191~200 (2013)
- Yamaguchi Y, "Regulation of skin pigmentation and thickness by Dickkopf 1(DKK1)", J Investig Dermatol Symp Proc, 14, pp.73~75 (2009)
- Hwang I, "Neural stem cells inhibit melanin production by activation of Wnt inhibitors", J Dermatol Sci, 72, pp.274~283 (2013)
- Wang X, "Feedback activation of basic fibroblast growth factor signaling via the Wnt", β-catenin pathway in skin fibroblasts, 2017, pp.8, 32~
- Rokhsar CK, "The treatment of melasma with fractional photothermolysis : a pilot study", Dermatol Surg, 31, pp.1645~1650 (2005)
- Kim HS, "A splitface comparison of low-fluence Q-switched Nd : YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd : YAG monotherapy for facial melasma in Asian skin", J Cosmet Laser Ther, 15, pp.143~149 (2013)
- Brauer JA, "Evaluation of a low energy, low density, non-ablative fractional 1927nm wavelength laser for facial skin resurfacing", J Drugs Dermatol, 14, pp.1262~1267 (2015)
- Chan CS, "Combined treatment for facial rejuvenation using an optimized pulsed light source followed by a fractional non-ablative laser", Lasers Surg Med, 45, pp.405~409 (2013)
- Wanitphakdeedecha R, "The efficacy in treatment of facial melasma with thulium 1927-nm fractional laserassisted topical tranexamic acid delivery : a split-face, doubleblind, randomized controlled pilot study", Lasers Med Sci, 35, pp.2015~2021 (2020)